
The news broke last week that scientists in the US had carried out the first gene editing testing in the …

If there was a company that needed a series of good news stories this week, it was AstraZeneca. The blow …

Bicycle Theapeutics, a biotech that is developing its bicyclic peptide product platform, has announced the appointed of Lee Kalowski as …

The FDA has given its approval for the commercialisation of Celgene and Agios Pharmaceutical’s Idhifa for the treatment of relapsed …

Numbers released by the Office for National Statistics (ONC) has revealed that drug misuse deaths were at a record high, …

The uncertainty caused by Brexit has been and continues to be far-reaching, and perhaps most impactful for business, organisations and …

Daiichi Sankyo has settled a case alleging that it did not fully disclose adverse side-effects of its drug, Benicar, with …

Pfizer revealed in its briefing on its second quarter financials that Ibrance, its breast cancer treatment, had grown in sales …

Pfizer has had a tough time keeping hold of its Vice President’s involved in R&D of late, losing high-profile researcher, …

It’s been a rollercoaster week for AstraZeneca.

Boehringer Ingelheim announced that it had broken ground on its planned $217 million upgrade and expansion of its existing Fermont …

As of today, all babies born in the UK will be administered with the vaccine for hepatitis B, with the …

Torbay Pharmaceuticals conducted a grand unveiling to open its £26 million pharmaceuticals manufacturing unit – the largest NHS manufacturer of …

Last month saw the formation of the Brexit Health Alliance, a partnering of key pharma and life sciences organisations including …

The reputation of large pharma companies in the UK was revealed to be well below the global average, in PatientView’s …